G S Leverich
Affiliation: National Institutes of Health
- The Stanley Foundation Bipolar Treatment Outcome Network. I. Longitudinal methodologyG S Leverich
Biological Psychiatry Branch, National Institute of Mental Health, Bethesda, MD 20892 1272, USA
J Affect Disord 67:33-44. 2001..This article describes the rationale for the Network, its guiding principles, methods, and study design to systematically assess the highly variable course of bipolar illness and its response to current and future treatments...
- Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizersR M Post
Biological Psychiatry Branch, NIMH, NIH, Bethesda, MD 20892-1272, USA
Bipolar Disord 3:259-65. 2001..Individual data on each drug will be assessed in the next phase of the study after more subjects are recruited and the blind is broken...
- The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patientsT Suppes
The Stanley Foundation Bipolar Network, 5430 Grosvenor Lane, Suite 200, Bethesda, MD 20814, USA
J Affect Disord 67:45-59. 2001..This report describes the demographics and course of illness characteristics of this study population...
- The Stanley Foundation Bipolar Network. I. Rationale and methodsR M Post
National Institute of Mental Health, Bethesda, Maryland, USA
Br J Psychiatry Suppl 41:s169-76. 2001..CONCLUSIONS: Well-characterised patients are followed in a detailed continuous longitudinal fashion in both opportunistic case series and double-blind, randomised controlled trials with reliable and validated measures...
- Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertralineR M Post
Department of Health and Human Services, National Institute of Mental Health, Bethesda, Maryland, USA
Br J Psychiatry 189:124-31. 2006..Few studies have examined the relative risks of switching into hypomania or mania associated with second-generation antidepressant drugs in bipolar depression...
- Relationship between prior course of illness and neuropsychological functioning in patients with bipolar disorderK D Denicoff
Section on Psychobiology, Biological Psychiatry Branch, National Institute of Mental Health, Bethesda, MD 20892, USA
J Affect Disord 56:67-73. 1999..This study investigated the relationship between prior course of illness and neuropsychological deficits in relatively high functioning outpatients with bipolar disorder...
- Relationship between prior course of illness and neuroanatomic structures in bipolar disorder: a preliminary studyS O Ali
Section on Psychobiology, Biological Psychiatry Branch, National Institute of Mental Health, Bethesda, Maryland 20892, USA
Neuropsychiatry Neuropsychol Behav Neurol 14:227-32. 2001..CONCLUSIONS: Additional studies are needed to both replicate and further examine the association of prior course of illness and larger hippocampal and ventricular volumes in bipolar disorder...
- Developmental vulnerabilities to the onset and course of bipolar disorderR M Post
Biological Psychiatry Branch, National Institute of Mental Health, Bethesda, MD 20892-1272, USA
Dev Psychopathol 13:581-98. 2001....
- Use of quetiapine in bipolar disorder: a case series with prospective evaluationT Suppes
Int Clin Psychopharmacol 19:173-4. 2004..Somatic complaints were limited. Mean (SD) duration before changes in medication regimens was 134 (100) days. Studies of the use of quetiapine in maintenance treatment of bipolar disorder are warranted...
- The role of psychosocial stress in the onset and progression of bipolar disorder and its comorbidities: the need for earlier and alternative modes of therapeutic interventionR M Post
Penn State University School of Medicine, USA
Dev Psychopathol 18:1181-211. 2006..Without the mobilization of new clinical and public health approaches to earlier and more effective treatment and supportive interventions, bipolar illness will continue to have grave implications for many patients' long-term well being...
- Tranylcypromine vs. lamotrigine in the treatment of refractory bipolar depression: a failed but clinically useful studyW A Nolen
University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
Acta Psychiatr Scand 115:360-5. 2007..To compare the efficacy and tolerability of tranylcypromine vs. lamotrigine in bipolar depression not responding to conventional antidepressants...